Royal Bank of Canada’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-8,310
| Closed | -$564K | – | 6550 |
|
2019
Q3 | $564K | Sell |
8,310
-1,762
| -17% | -$120K | ﹤0.01% | 3237 |
|
2019
Q2 | $585K | Buy |
10,072
+1,466
| +17% | +$85.1K | ﹤0.01% | 3233 |
|
2019
Q1 | $603K | Buy |
8,606
+7,999
| +1,318% | +$560K | ﹤0.01% | 3108 |
|
2018
Q4 | $39K | Sell |
607
-382
| -39% | -$24.5K | ﹤0.01% | 4562 |
|
2018
Q3 | $69K | Buy |
989
+220
| +29% | +$15.3K | ﹤0.01% | 4476 |
|
2018
Q2 | $39K | Buy |
769
+608
| +378% | +$30.8K | ﹤0.01% | 4687 |
|
2018
Q1 | $5K | Sell |
161
-93
| -37% | -$2.89K | ﹤0.01% | 5350 |
|
2017
Q4 | $8K | Sell |
254
-1,698
| -87% | -$53.5K | ﹤0.01% | 5204 |
|
2017
Q3 | $63K | Buy |
1,952
+1,763
| +933% | +$56.9K | ﹤0.01% | 4557 |
|
2017
Q2 | $6K | Sell |
189
-900
| -83% | -$28.6K | ﹤0.01% | 5255 |
|
2017
Q1 | $33K | Sell |
1,089
-266
| -20% | -$8.06K | ﹤0.01% | 4708 |
|
2016
Q4 | $40K | Buy |
1,355
+1,254
| +1,242% | +$37K | ﹤0.01% | 4647 |
|
2016
Q3 | $3K | Sell |
101
-3,365
| -97% | -$100K | ﹤0.01% | 5358 |
|
2016
Q2 | $90K | Sell |
3,466
-5,037
| -59% | -$131K | ﹤0.01% | 4157 |
|
2016
Q1 | $210K | Buy |
8,503
+8,375
| +6,543% | +$207K | ﹤0.01% | 3702 |
|
2015
Q4 | $5K | Sell |
128
-14,900
| -99% | -$582K | ﹤0.01% | 5407 |
|
2015
Q3 | $317K | Buy |
15,028
+4,494
| +43% | +$94.8K | ﹤0.01% | 3386 |
|
2015
Q2 | $293K | Buy |
10,534
+10,209
| +3,141% | +$284K | ﹤0.01% | 3605 |
|
2015
Q1 | $10K | Sell |
325
-19,945
| -98% | -$614K | ﹤0.01% | 5126 |
|
2014
Q4 | $648K | Buy |
20,270
+17,540
| +642% | +$561K | ﹤0.01% | 2801 |
|
2014
Q3 | $77K | Sell |
2,730
-6,975
| -72% | -$197K | ﹤0.01% | 4206 |
|
2014
Q2 | $266K | Buy |
9,705
+8,705
| +871% | +$239K | ﹤0.01% | 3480 |
|
2014
Q1 | $26K | Sell |
1,000
-21,533
| -96% | -$560K | ﹤0.01% | 4573 |
|
2013
Q4 | $660K | Buy |
22,533
+6,835
| +44% | +$200K | ﹤0.01% | 2663 |
|
2013
Q3 | $480K | Buy |
15,698
+4,130
| +36% | +$126K | ﹤0.01% | 2906 |
|
2013
Q2 | $366K | Buy |
+11,568
| New | +$366K | ﹤0.01% | 2898 |
|